A detailed history of Adams Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Adams Wealth Management holds 454 shares of LLY stock, worth $338,774. This represents 0.09% of its overall portfolio holdings.

Number of Shares
454
Previous 409 11.0%
Holding current value
$338,774
Previous $370,000 8.65%
% of portfolio
0.09%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$772.14 - $960.02 $34,746 - $43,200
45 Added 11.0%
454 $402,000
Q2 2024

Jul 16, 2024

BUY
$724.87 - $909.04 $43,492 - $54,542
60 Added 17.19%
409 $370,000
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $183,291 - $216,076
349 New
349 $203,000
Q4 2020

Feb 08, 2021

SELL
$130.46 - $172.63 $47,748 - $63,182
-366 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $53,516 - $61,901
366 New
366 $54,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Adams Wealth Management Portfolio

Follow Adams Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Adams Wealth Management with notifications on news.